Gene Green said...

The Improving Regulatory Transparency for New Medical Therapies Act provides a solution to current delays experienced by patients in need.

Gene Green highlights legislation aimed at reducing delays in patient access to new therapies.

01/26/2015

More Gene Green Quotes

In addition to addressing antimicrobial resistance, we also need to further consider the proposal to move the Strategic ...

While were a still great success in the last decade, the sun doesn't always shine and the wind doesn't always blow.

I believe the creation of a market entry reward program that incentivize the manufacturers to develop novel antibiotics ...

If we don't fund those programs, like I said, we can pass all the bills we want, it just won't help us with people being...